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Abstract: Amyloid-β peptide (Aβ) isoforms of different lengths and 
aggregation propensities coexist in vivo. These different isoforms are 
able to nucleate or frustrate the assembly of each other. N-terminal 
truncated Aβ(11-40) and Aβ(11-42) make up one fifth of plaque load yet 
nothing is known about their interaction with full-length Aβ(1-40/42). 
Here we show that in contrast to C-terminal truncated isoforms 
which do not co-fibrillise, deletions of ten residues from the N-
terminus of Aβ have little impact on its ability to co-fibrillise with the 
full-length counterpart. As a consequence N-terminal truncated Aβ 
will accelerate fibre formation and co-assemble into short rod-
shaped fibres with its full-length Aβ counterpart. This has 
implications for the assembly kinetics, morphology and toxicity of all 
Aβ isoforms.  
Misfolding and self-assembly of an endogenous peptide, 
amyloid-β (Aβ), into toxic oligomers and amyloid fibres is central 
to the amyloid cascade in Alzheimer’s Disease (AD) 
[1]
. The 40 
or 42 amino acids long peptide, Aβ(1-40/42), is released as a 
cleavage product of the amyloid precursor protein (APP), by the 
action of the β- and γ- secretase complex. However both the β- 
and γ-secretases have variable site specificity for APP and 
produce different lengths of Aβ 
[2]
. The main N-truncated form of 
Aβ is generated by secondary β-secretase activity (βʹ) which 
produces Aβ(11-40/42) 
[3]
, although other N-truncated and extended 
forms of Aβ are also formed 
[4]
. Aβ(11-40/42) is at least as abundant 
as Aβ(1-42) in the cerebrospinal fluid (CSF) 
[5]
 and makes up one-
fifth of plaque load 
[6]
. Intriguingly, Aβ(11-40/42) and the N-terminal 
pyroglutamate form are concentrated at the core of plaques in 
AD brains 
[7]
. Furthermore, some familial forms of AD are noted 
for increasing the level of Aβ(1-42) but also elevate levels of Aβ(11-
42) by as much as 33-42% 
[8]
.  There is much interest in the 
interaction of Aβ(1-40) with Aβ(1-42), that are both present in 
plaques, as changes in the ratio of 42/40 are linked with 
inherited AD 
[9]
. It is clear that one Aβ isoform influences the 
fibre formation kinetics of the other 
[10]
. 
Despite Aβ(11-40/42) being a major component of plaques 
and CSF (20 % of plaque load) 
[5-6]
, there has been little 
biophysical characterisation of N-terminally truncated Aβ. We 
have recently shown that Aβ(11-40/42) binds Cu
2+ 
with an extremely 
tight femtomolar affinity and forms amyloid fibres much more 
rapidly than Aβ(1-40) 
[11]
. Here we aim to probe the impact Aβ(11-
40/42) has on the amyloid assembly of full-length Aβ isoforms. This 
study provides insight into the role of the first ten residues in the 
protofibril assembly pathway and the impact on the kinetics of 
assembly and fibre stability; both in isolation and in 
physiologically relevant mixtures. 
In marked contrast to full-length Aβ(1-40) and Aβ(1-42), 
quiescently grown fibres of Aβ(11-40) and Aβ(11-42) readily 
fragmented with mild agitation, generating short amyloid rods, 
with a mean length of 150 nm, see supplemental figure S1 and 
S2. Although residues 1-10 are not thought to form hydrogen-
bonded strands in Aβ(1-40) or Aβ(1-42) fibres 
[12]
, it is clear they 
contribute to stability of the fibres and resistance to mechanical 
shear forces. A similar tendency to fragment has been reported 
for another N-terminal truncated form of Aβ, residues 4-40 
[4b]
. 
We also addressed the possibility that the loss of the ten N-
terminal residues may modulate formation of prefibrillar 
assemblies. TEM micrographs show a snap-shot of the pre-
fibrillar structural morphologies present at given times during 
Aβ(11-40) and Aβ(11-42) assembly, supplemental figure S3, S4 and 
S5. Very similar circular oligomeric structural morphologies, 
between 5-40 nm in diameter, and curvy-linear protofibrillar 
structures were observed, in the early stages of assembly, 
across all isoforms irrespective of the N-terminal truncation. In 
contrast to current understanding 
[13]
, our TEM studies show the 
first ten residues of Aβ are not a requirement for the formation of 
oligomers and curvy protofibrillar assemblies.  
Although Aβ(11-40/42) is a major component of plaques, 
nothing is known about how it might influence Aβ(1-40/42) fibre 
formation. ThT fluorescence was used to monitor fibre formation 
of Aβ(1-40) and Aβ(11-40) mixtures, under the influence of mild 
agitation. Both isoforms produce time-dependent ThT 
fluorescence signals with a sigmoidal curve associated with a 
slow lag-phase (nucleation) followed by rapid fibre elongation as 
Aβ monomer is recruited to the growing ends of fibres, before 
the maximal signal plateaus at equilibrium, figure 1A. Aβ (11-40) 
lag-times (19 ± 1 hrs) are markedly shorter than Aβ(1-40) (99 ± 3 
hrs) under identical conditions. Next the ThT signal was 
monitored for equimolar mixtures of Aβ(11-40) and Aβ(1-40), figure 
1A. The ThT traces have a lag-phase of 61 ± 1 hours; an 
intermediate time between Aβ(11-40) and Aβ(1-40). Fibre formation 
of Aβ(1-40) is accelerated by the presence of Aβ(11-40). Indeed the 
mixed isoforms have intermediate formation kinetics which 
linearly correlate with the ratio of Aβ(11-40) and Aβ(1-40), 
supplemental figure S6. The combined rate constants for 
nucleation and elongation are a weighted average of the rate 
constants for the Aβ isoforms in isolation, supplemental figure 
S6.  Any mixed assemblies that form, do not slow fibre formation 
of Aβ(1-40) suggesting they are not off-pathway and form part of 
the final fibre. This behaviour with the absence of a biphasic 
curve raises the possibility that Aβ(11-40) and Aβ(1-40) might co-
fibrillise. This is supported by the markedly different fibre 
formation kinetics observed for mixtures of Aβ(11-40) with Aβ(1-42), 
figure 1b and supplemental figure S7. Rather than accelerating 
Aβ(1-42) fibre formation, as was observed for Aβ(1-40), the Aβ(11-40) 
with Aβ(1-42) mixture has frustrated fibre formation kinetics. In this 
case the equimolar mixture has a longer lag-phase than both 
Aβ(11-40) and Aβ(1-42) individually; 62 ± 3 hours for the binary 
mixture, compared to lag-times of 6.6 ± 0.3 hours and 37 ± 2 
hours respectively. Suggesting for this Aβ isoform combination 
initial co-aggregated oligomers are off-pathway to forming 
individual fibres and so slow fibre assembly. Furthermore this 
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combination of isoforms produces biphasic kinetic behaviour, 
which is consistent with independent fibre formation, see 
suppleimental figure S7 in particular.  Biphasic kinetics has also 
recently been reported for Aβ(1-40) with Aβ(1-42) mixtures 
[10d ]













Figure 1. Fibrillisation of  Aβ(11-40) with full-length Aβ.  Fiber formation 
monitored by ThT fluorescence. Equimolar mixture of Aβ(11-40) and Aβ (1-40) 
(green) compared with Aβ(11-40) (blue) and Aβ(1-40) (red) kinetic traces (a). 
Equimolar mixture of Aβ(11-40) and Aβ(1-42) (green) compared with Aβ(11-40) (blue) 
and Aβ (1-42) (red) kinetic traces (b), at pH 7.4, total Aβ 10 µM,  n = 6 traces,  
 
The strongest support for a high proportion of co-
fibrilisation for Aβ(11-40)/(1-40) but not Aβ(11-40)/(1-42) comes from TEM 
data. In mixtures of Aβ(11-40)/(1-40), only short rod-like fibres are 
observed, similar in length to Aβ(11-40) in isolation, figure 2a.  If 
Aβ(11-40) and Aβ(1-40) form fibres independently one would expect 
very long fibres to also be present, as is observed for Aβ(1-40) in 
isolation.  Quantification of fibre length distribution, (figure 2a) 
indicates only very short fibres (<400 nm) are consistently 
present.  Incorporation of Aβ(11-40) into Aβ(1-40) fibres imparts 
these fibres with a similar susceptibility to sheer forces as 
isolated Aβ(11-40). This behaviour is in marked contrast to the 
binary mixture of Aβ(11-40)/(1-42) this mixture does not co-fibrillise 
and these fibres form independently.  For this mixture, there is 
an equal proportion of long fibres, very similar in length 
distribution to Aβ(1-42), together with very short fibre-rods very 

















Figure 2: Fibre length distribution for Aβ isoforms in isolation and as 
mixtures. A binary mixture of Aβ(11-40) with Aβ(1-40), exclusively short fibre 
rods are present < 400 nm, indicating cofibrilization (a). Aβ(11-40) with Aβ(1-
42) binary mixture; combination of short and long fibres are present, 
indicating the isoforms form fibres separately (b). TEM scale bar 200 nm. 
Typically >2000 fibre lengths were measured per condition. 
Similarly fibre length distributions have been quantified for Aβ(11-
42)+(1-40)  and Aβ(11-42)+(1-42) binary mixtures, see supplemental 
figure S8.  Aβ isoforms with the same C-termini co-fibrillise 
producing only short amyloid rods. In contrast, Aβ(11-42)+(1-40)  
produce fibres independently and exhibit both long fibres and 
short rods. 
 To further support the assertion Aβ(11-40) and Aβ(1-40) fibres 
co-assemble we used 
1
H-NMR to monitor fibre growth. Spectra 
of Aβ(11-40) and Aβ(1-40) in D2O at pH 7.4 reveal well resolved and 
characteristic δH resonances for His13 and His14, these peaks 
are shifted downfield for the Aβ(11-40)  peptide at pH 7.4, as shown 
in figure 3A. Tyr10 and His6 side chain resonances were 
assigned for Aβ(1-40) but are absent in the Aβ(11-40) spectra. 1D 
1
H-
NMR spectra of an equimolar mixture of both peptides were 
acquired over several hours with mild agitation generated by 
cycles of sample spinning in the NMR tube between spectra 
acquisitions. The increase in line-width and consequent 
complete loss of signal for fibre assemblies (which are mega-
daltons in size) can be plotted over time to monitor the rate of 
loss of Aβ monomer, this corresponds to an assembly growth 
curve, as shown in figure 3B. The NMR experiment enables 
monitoring fibre growth of Aβ(11-40) and Aβ(1-40) independently from 
within an equimolar mixture. The lag-times are almost identical 
for both peptides at 7.5 hours whilst the apparent elongation 
rates kapp are also very similar; 0.15 and 0.17 (± 0.02) hrs
-1
 for 
Aβ(1-40) and Aβ(11-40) respectively. This strongly suggests that, in 
the case of Aβ(1-40) and Aβ(11-40), the fibres largely co-fibrillise. It 
is notable that for similar NMR experiments on Aβ(1-40) with Aβ(1-
42) mixtures, which do not co-fibrillise, very different fibre growth 


















Figure 3: Fibrillisation of an equimolar mixture of Aβ(11-40) with Aβ(1-40), 20 
µM, monitored by 
1
H-NMR.  Spectra of Aβ(11-40) and Aβ(1-40), along with 
the 1:1 mixture and subsequent loss of signal over time (a). Time course 
of the integrated His δH resonances for Aβ(11-40) and Aβ(1-40) peptides at 
pH 7.4 (b). 
 
Next we investigated the ability for small amounts of fibres 
from different Aβ isoforms to nucleate fibre formation of the 
monomeric Aβ(1-40), figure 4.  As expected, addition of small 
amounts of Aβ(1-40) fibre seeds (10%) reduces the lag-times for 
fibre formation of Aβ(1-40) monomer, figure 4. Similarly Aβ(11-40) 
fibres were able to cross-seed Aβ(1-40) fibre formation to the 
same extent, supporting the assertion these two isoforms, with 
the same C-terminus, are able to co-fibrillise. In contrast, 
nucleating seeds with the longer C-terminus; Aβ(11-42) and Aβ(1-42) 
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experiments show co-fibrallisation of Aβ(1-40) with Aβ(11-40) occurs 
at the elongation and/or secondary surface nucleation stage of 
assembly. While Aβ(11-42) fibres do not cross-seed Aβ(1-40) fibre 
formation, see supplemental figure S9 for details. 
                   
Figure 4:  Seeded fibre formation of monomeric Aβ(1-40). In the absence 
(black) and presence of a 10 % nucleating fibre seed.  Aβ(1-40) is 
nucleated by Aβ(11-40) (pale blue) and Aβ(1-40) (dark blue), but not by Aβ(1-
42) (red) or Aβ(11-42) seeds (pink) at pH 7.4, Aβ(1-40) 10 µM, n = 3 traces. 
 
Studies on the assembly of Aβ(1-40) with Aβ(1-42) show that 
for the C-terminal truncations the two isoforms interact during 
early oligomerization, but go on to form fibres independently 
[10d, 
10e]
. The lack of co-assembly between Aβ(1-40) with Aβ(1-42) is 
presumably due to the marked differences in their respective 
fibre structures, with a U-shaped topology for Aβ(1-40) and S-
shaped topology for Aβ(1-42) fibril cores 
[12]
. This structural 
difference is centred on the formation of a salt-bridge between 
Lys28 and the C-terminal carboxylate of Ala42 
[12a]
. In contrast to 
the loss of two residues at the C-terminus, our fibre formation 
kinetics, TEM and 
1
H-NMR suggest that the loss of 10 residues 
from the N-terminus does not prevent fibre co-assembly of Aβ(1-
40) with Aβ(11-40). Very different interactions take place for Aβ(11-40) 
mixed with Aβ(1-42); the formation of fibres for this combination of 
isoforms is biphasic and is frustrated. These observations 
suggest that fibre structural topology is unaffected by the loss of 
the first ten N-terminal residues and so there is little difference in 
the affinity of Aβ(1-40) or Aβ(11-40) monomer addition to the ends of 
growing mixed fibres, which facilitates co-fibrillisation, see 
supplemental figure S10. 
Aβ(11-40/42) assemblies are a major component (one fifth) of 
plaques and CSF 
[5-6]
. The accelerated assembly of Aβ in the 
presence of N-terminally truncated Aβ has profound 
ramifications for plaque formation and AD pathology. The impact 
on mechanical stability of co-assembled fibres also has 
implications for their neurotoxicity, as fragmented fibres are 
thought to be more cytotoxic 
[14]
. There are a number of other Aβ 
isoforms truncated or extended at both the N- and C-termini 
[2, 4]
. 
It may be that truncations at the N-terminus such as Aβ(4-40/42) 
and Aβ(3-40/42) will also accelerate fibre formation and allow co-
fibrillisation of their full-length counterparts. Indeed co-
fibrillisation has been reported for the N-terminal extended 
isoform of Aβ 
[4a ]
. In contrast, Aβ truncations at the C-terminus 
impact fibre structural topology 
[12a, 14]
 and do not co-assemble 
and consequently cause the frustration of fibre formation kinetics. 
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